Source:http://linkedlifedata.com/resource/chebi/id/CHEBI:6343
| Predicate | Object |
|---|---|
| rdf:type | |
| skos:definition |
"A secondary amino compound formally derived from ammonia by replacing two of the hydrogens by 2-(3-carbamoyl-4-hydroxyphenyl)-2-hydroxyethyl and 4-phenylbutan-2-yl groups. It is an adrenergic antagonist used to treat high blood pressure." []
|
| skos:inScheme | |
| skos:prefLabel |
labetalol
|
| skos:altLabel |
2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide,
Labetalol
|
| skos:notation |
Beilstein:2948416 "Beilstein Registry Number",
ChemIDplus:36894-69-6 "CAS Registry Number",
CiteXplore:21908132 "PubMed citation",
CiteXplore:22300487 "PubMed citation",
CiteXplore:22528277 "PubMed citation",
CiteXplore:23055089 "PubMed citation",
DrugBank:DB00598 "DrugBank",
HMDB:HMDB14736 "HMDB",
KEGG COMPOUND:C07063 "KEGG COMPOUND",
Patent:DE2032642 "Patent",
Patent:US4012444 "Patent",
Reaxys:2948416 "Reaxys Registry Number",
Wikipedia:Labetalol "Wikipedia"
|
| skos:broader | |
| skos:relatedSynonym |
labetalol,
labetalolum,
3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol,
5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide,
C19H24N2O3,
CC(CCc1ccccc1)NCC(O)c1ccc(O)c(c1)C(N)=O,
InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24),
InChIKey=SGUAFYQXFOLMHL-UHFFFAOYSA-N
|